ID   HCM-MEC010
AC   CVCL_B7H4
SY   Hyogo College of Medicine-MucoEpidermoid Carcinoma 010
DR   Wikidata; Q112929645
RX   PubMed=35251626;
CC   Population: Japanese.
CC   Sequence variation: Gene fusion; HGNC; HGNC:16062; CRTC1 + HGNC; HGNC:16259; MAML2; Name(s)=CRTC1-MAML2, MECT1-MAML2; Note=In frame. CRTC1 exon 1 fused to MAML2 exon 2 (PubMed=35251626).
CC   Omics: Transcriptomics; RNAseq.
CC   Derived from site: In situ; Oral cavity, hard palate; UBERON=UBERON_0003216.
ST   Source(s): PubMed=35251626
ST   Amelogenin: X,Y
ST   CSF1PO: 9,12
ST   D13S317: 10,11
ST   D16S539: 12,13
ST   D21S11: 29,30
ST   D5S818: 10,14
ST   D7S820: 11,12
ST   TH01: 7,9
ST   TPOX: 8
ST   vWA: 14,18
DI   NCIt; C6214; Hard palate mucoepidermoid carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   45Y
CA   Cancer cell line
DT   Created: 23-06-22; Last updated: 10-04-25; Version: 6
//
RX   PubMed=35251626; DOI=10.3892/mco.2022.2508; PMCID=PMC8848773;
RA   Noguchi K., Kanda S., Yoshida K., Funaoka Y., Yamanegi K.,
RA   Yoshikawa K., Takaoka K., Kishimoto H., Nakano Y.;
RT   "Establishment of a patient-derived mucoepidermoid carcinoma cell line
RT   with the CRTC1-MAML2 fusion gene.";
RL   Mol. Clin. Oncol. 16:75.1-75.12(2022).
//